(Q46040626)

18 December 2017

title

Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs (English)

1 reference

18 December 2017

3

Salim Yusuf

1 reference

18 December 2017

Janice Pogue

series ordinal

1

object named as

Janice Pogue

1 reference

18 December 2017

author name string

Stephen D Walter

series ordinal

2

1 reference

18 December 2017

publication date

1 June 2009

1 reference

18 December 2017

published in

Clinical Trials

1 reference

18 December 2017

volume

6

1 reference

18 December 2017

issue

3

1 reference

18 December 2017

page(s)

239-251

1 reference

18 December 2017

Outcome assessment for clinical trials: how many adjudicators do we need? Canadian Lung Oncology Group.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

Differences in difficulty adjudicating clinical events in patients with advanced HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

The Coronary Drug Project. External quality control programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

Systematic adjudication of myocardial infarction end-points in an international clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

Comparing classifications of death in the Mode Selection Trial: agreement and disagreement among site investigators and a clinical events committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

The impact of an end-point committee in a large multicentre, randomized, placebo-controlled clinical trial: results with and without the end-point committee's final decision on end-points

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

Do we need to adjudicate major clinical events?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

Homocysteine lowering with folic acid and B vitamins in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

Comparison of fondaparinux and enoxaparin in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

Oral anticoagulant and antiplatelet therapy and peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774509105223

21 January 2018

Identifiers

DOI

10.1177/1740774509105223

1 reference

18 December 2017

1 reference

18 December 2017